Literature DB >> 17207708

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Rene J Duquesnoy1, Medhat Askar.   

Abstract

This report describes the design of the eplet version of HLAMatchmaker to determine class II compatibility at the structural level. This matching algorithm is based on the hypothesis, developed from molecular modeling of crystallized antigen-antibody complexes, that functional epitopes are represented by patches of surface-exposed nonself-amino acid residues surrounded by residues within a 3-A radius. Patch determinations with a molecular viewer of crystalline structural models downloaded from the Entrez Molecular Modeling Database Web site led to the identification of 44 DRB, 33DQB, 29 DQA, 20 DPB, and 9 DPA unique combinations of polymorphic positions. The residue compositions of these patches were then determined from amino acid sequences. This analysis resulted in a repertoire of 146 DRB, 74 DQB, 58 DQA, 45 DPB, and 19 DPA eplets. In many eplets, the residues are in short linear sequences, but many other eplets have discontinuous sequences of residues that cluster on or near the molecular surface. This analysis has also shown that all serologically defined DR and DQ antigens detectable by monospecific antibodies have unique eplets. Other eplets are present in groups of class II antigens, many of which appear as cross-reacting. The eplet version of HLAMatchmaker should be considered as a hypothetical model for the structural assessment of donor-recipient compatibility and the determination of mismatch acceptability for sensitized patients. This computer algorithm can be downloaded from the HLA Matchmaker Webside at http://tpis.upmc.edu.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207708      PMCID: PMC2527859          DOI: 10.1016/j.humimm.2006.10.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  55 in total

1.  Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.

Authors:  Howard M Gebel; Robert A Bray; Peter Nickerson
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

2.  Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.

Authors:  Christian Siebold; Bjarke E Hansen; Jessica R Wyer; Karl Harlos; Robert E Esnouf; Arne Svejgaard; John I Bell; Jack L Strominger; E Yvonne Jones; Lars Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

3.  MMDB: Entrez's 3D-structure database.

Authors:  Jie Chen; John B Anderson; Carol DeWeese-Scott; Natalie D Fedorova; Lewis Y Geer; Siqian He; David I Hurwitz; John D Jackson; Aviva R Jacobs; Christopher J Lanczycki; Cynthia A Liebert; Chunlei Liu; Thomas Madej; Aron Marchler-Bauer; Gabriele H Marchler; Raja Mazumder; Anastasia N Nikolskaya; Bachoti S Rao; Anna R Panchenko; Benjamin A Shoemaker; Vahan Simonyan; James S Song; Paul A Thiessen; Sona Vasudevan; Yanli Wang; Roxanne A Yamashita; Jodie J Yin; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

4.  New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans.

Authors:  W Klitz; M Maiers; S Spellman; L A Baxter-Lowe; B Schmeckpeper; T M Williams; M Fernandez-Viña
Journal:  Tissue Antigens       Date:  2003-10

5.  Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period.

Authors:  Aliki G Iniotaki-Theodoraki; John N Boletis; George Ch Trigas; Helen G Kalogeropoulou; Alkiviadis G Kostakis; Catherine G Stavropoulos-Giokas
Journal:  Transplantation       Date:  2003-05-15       Impact factor: 4.939

Review 6.  Humoral theory of transplantation.

Authors:  Paul I Terasaki
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

7.  Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.

Authors:  Daniel Böhringer; Thomas Reinhard; René J Duquesnoy; Stefan Böhringer; Jürgen Enczmann; Peter Lange; Frans Claas; Rainer Sundmacher
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

8.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex.

Authors:  James Robinson; Matthew J Waller; Peter Parham; Natasja de Groot; Ronald Bontrop; Lorna J Kennedy; Peter Stoehr; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

9.  HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.

Authors:  Rene J Duquesnoy; Marian Witvliet; Ilias I N Doxiadis; Hans de Fijter; Frans H J Claas
Journal:  Transpl Int       Date:  2003-08-30       Impact factor: 3.782

10.  A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants.

Authors:  Gunter Laux; Ulrich Mansmann; Ariane Deufel; Gerhard Opelz; Joannis Mytilineos
Journal:  Transplantation       Date:  2003-05-15       Impact factor: 4.939

View more
  39 in total

1.  Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.

Authors:  Kathryn J Tinckam; Caren Rose; Sundaram Hariharan; John Gill
Journal:  J Am Soc Nephrol       Date:  2016-02-17       Impact factor: 10.121

2.  HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Blood Adv       Date:  2018-12-26

Review 3.  Moving Biomarkers toward Clinical Implementation in Kidney Transplantation.

Authors:  Madhav C Menon; Barbara Murphy; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2017-01-06       Impact factor: 10.121

4.  The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-26       Impact factor: 5.742

5.  Molecular Mismatch-the Renaissance of HLA in Kidney Transplantation.

Authors:  Chris Wiebe; Peter W Nickerson
Journal:  J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 10.121

6.  Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury.

Authors:  Jing Liu; Sanjeev Kumar; Andreas Heinzel; Michael Gao; Jinjin Guo; Gregory F Alvarado; Roman Reindl-Schwaighofer; A Michaela Krautzberger; Pietro E Cippà; Jill McMahon; Rainer Oberbauer; Andrew P McMahon
Journal:  J Am Soc Nephrol       Date:  2020-02-07       Impact factor: 10.121

7.  Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.

Authors:  Chris Wiebe; David N Rush; Thomas E Nevins; Patricia E Birk; Tom Blydt-Hansen; Ian W Gibson; Aviva Goldberg; Julie Ho; Martin Karpinski; Denise Pochinco; Atul Sharma; Leroy Storsley; Arthur J Matas; Peter W Nickerson
Journal:  J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 10.121

8.  Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns.

Authors:  Rene J Duquesnoy; Justin Mostecki; Jayasree Hariharan; Ivan Balazs
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

9.  Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

Authors:  Rene J Duquesnoy; Yehia Awadalla; Jon Lomago; Larry Jelinek; Judy Howe; Dwayne Zern; Betty Hunter; Joan Martell; Alin Girnita; Adriana Zeevi
Journal:  Transpl Immunol       Date:  2007-10-30       Impact factor: 1.708

10.  Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

Authors:  Marilyn Marrari; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.